• NEDD4L Suppresses Colorectal Cancer Liver Metastasis via PRM

  2026-05-27

  This study demonstrates that the E3 ubiquitin ligase NEDD4L inhibits colorectal cancer liver metastasis by targeting PRMT5 for degradation, thereby attenuating AKT/mTOR signaling. The findings establish a novel mechanistic link between NEDD4L, PRMT5, and metastatic progression, offering new insights into potential therapeutic strategies.

• SCA27B in Poland: Systematic Review and Genetic Diagnosis Ad

  2026-05-27

  A recent systematic review and case report highlight the genetic and clinical landscape of spinocerebellar ataxia 27B (SCA27B), focusing on a Polish family and data from 815 cases. The study emphasizes the importance of GAA repeat expansions in FGF14 for diagnosing late-onset cerebellar ataxia, and provides detailed insights into clinical manifestations, genetic testing protocols, and the challenges of variable phenotypic presentation.

• ML-7 Hydrochloride: Strategic MLCK Inhibition for Translatio

  2026-05-26

  This thought-leadership article explores the mechanistic and strategic advances of ML-7 hydrochloride as a selective myosin light chain kinase inhibitor, emphasizing its pivotal role in cardiovascular, endothelial, and cell motility research. Drawing on recent mechanistic insights and translational models, it guides researchers through experimental best practices, highlights competitive differentiators, and outlines actionable protocol parameters. By integrating evidence from host-pathogen cell entry studies and next-generation cardiovascular models, this article positions ML-7 hydrochloride as an essential tool for researchers seeking to decode MLCK-mediated phosphorylation and its translational applications.

• Dasatinib Monohydrate (BMS-354825): Reliable Assay Solutions

  2026-05-26

  This authoritative guide addresses persistent experimental challenges in cell viability and kinase inhibition assays, illustrating how Dasatinib Monohydrate (SKU B5954) enhances reproducibility and sensitivity in chronic myeloid leukemia research. Scenario-driven insights enable biomedical researchers and lab technicians to optimize workflow reliability by leveraging validated performance data and supplier trust.

• Fucoidan Mitigates Chemotherapy-Induced Steatohepatitis via

  2026-05-25

  This study reveals that fucoidan, a sulfated α-L-fucan, protects against irinotecan-induced steatohepatitis by restoring gut barrier integrity and suppressing hepatic neutrophil extracellular trap formation. These findings provide a mechanistic basis for using fucoidan to reduce chemotherapy-related liver injury while preserving gut–liver homeostasis.

• miR-519d Triggers Autophagy and Apoptosis in HCC via Rab10–A

  2026-05-25

  This study uncovers that microRNA-519d suppresses hepatocellular carcinoma cell proliferation by downregulating Rab10 and activating the AMPK signaling pathway, thereby inducing both autophagy and apoptosis. These findings highlight miR-519d as a promising molecular target for therapeutic strategies in HCC.

• CXCR4 Theranostic Imaging and Precision Therapy in Lymphoma

  2026-05-24

  This review highlights advances in CXCR4-targeted imaging ligands and therapeutic strategies for lymphoma, focusing on the receptor's role in tumor progression and treatment resistance. The integration of molecular imaging with precision therapy offers new avenues for diagnosis and tailored interventions in aggressive hematologic malignancies.

• B. pseudomallei BipD Hijacks Host CRL3 Ligase to Promote Mit

  2026-05-23

  The referenced study reveals how Burkholderia pseudomallei BipD commandeers the host KLHL9/KLHL13/CUL3 E3 ligase to ubiquitinate the mitochondrial protein IMMT, triggering mitophagy and supporting bacterial survival. These mechanistic insights broaden understanding of pathogen manipulation of host quality control pathways and present new angles for therapeutic intervention.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Ion Transport Modu

  2026-05-22

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride advances research into intracellular pH regulation and endothelial injury. This article offers a critical, mechanistic analysis and practical guidance distinct from existing coverage.

• Viperin Disrupts Coronavirus Replication via nsp8 Targeting

  2026-05-22

  The reference study uncovers a conserved antiviral mechanism whereby viperin, an interferon-induced enzyme, inhibits coronavirus replication by binding non-structural protein 8 (nsp8), disrupting replication-transcription complex (RTC) assembly. These findings clarify viperin’s dual mechanism—direct RTC disruption and ddhCTP-mediated polymerase inhibition—offering new insights for antiviral strategies.

• Sodium Orthovanadate: Precision Modulation of Insulin Signal

  2026-05-21

  Explore how Sodium Orthovanadate (Na3VO4) enables precise control of phosphorylation states in insulin signaling research. This in-depth analysis uncovers unique mechanistic insights and advanced assay optimization strategies for metabolic pathway investigations.

• NU6300 Blocks Gasdermin D Cleavage and Palmitoylation in Pyr

  2026-05-21

  Jiang et al. identify NU6300 as a covalent inhibitor of gasdermin D (GSDMD), targeting cysteine-191 to block both its cleavage and palmitoylation. This work clarifies a novel mechanism for inhibiting pyroptotic cell death, with significant implications for studying and modulating inflammasome-driven diseases.

• Intercellular Transfer of Immunoproteasomes via Extracellula

  2026-05-20

  This study demonstrates that non-constitutive proteasomes, including immunoproteasomes, can be packaged into extracellular vesicles (EVs) and transmitted between cells—an unprecedented mechanism for regulating immune function. The findings have practical implications for autoimmune and inflammatory disease research, especially for approaches targeting immunoproteasome function.

• PDI Inhibition Enhances Panobinostat Efficacy in Multiple My

  2026-05-20

  This study demonstrates that combining the PDI inhibitor LTI6426 with the HDAC inhibitor panobinostat synergistically enhances anti-myeloma activity, even in proteasome inhibitor–resistant models. The findings support a strategy for lowering panobinostat doses to reduce toxicity while maintaining efficacy, with implications for optimizing multiple myeloma treatment regimens.

• CHIR 99021 trihydrochloride: Advanced GSK-3 Inhibitor Workfl

  2026-05-19

  CHIR 99021 trihydrochloride empowers high-fidelity control of stem cell fate and metabolic signaling in organoid and disease models. This article delivers practical workflow enhancements, troubleshooting insights, and data-backed protocol guidance for leveraging this potent GSK-3 inhibitor in advanced biomedical research.

16825 records 1/1122 page Next 12345 下5页 Last page